Dhingra Ankur's Form 4 filing
Summit Therapeutics Inc. (SMMT) · filed Aug 17, 2022
- Accession no.
- 0001599298-22-000102
- Filed
- Aug 17, 2022
- Trade date
- Aug 16, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $35.1K. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0001849682-23-000002 (Mar 8, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dhingra AnkurCIK 0001849682 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | Common Stock | PPurchaseAcquired | +11,557 | $0.97 | +$11,210.29 | 38,057 | Direct | |
| Aug 16, 2022 | Common Stock | PPurchaseAcquired | +24,658 | $0.97 | +$23,918.26 | 38,196 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.